Xspray Pharma AB (publ)

BATS-CHIXE:XSPRAS Stock Report

Market Cap: SEK 1.7b

Xspray Pharma Management

Management criteria checks 2/4

Xspray Pharma's CEO is Per Andersson, appointed in Jan 2006, has a tenure of 18.58 years. total yearly compensation is SEK3.74M, comprised of 70.5% salary and 29.5% bonuses, including company stock and options. directly owns 0.57% of the company’s shares, worth SEK10.03M. The average tenure of the management team and the board of directors is 0.8 years and 5.3 years respectively.

Key information

Per Andersson

Chief executive officer

SEK 3.7m

Total compensation

CEO salary percentage70.5%
CEO tenure18.6yrs
CEO ownership0.6%
Management average tenureless than a year
Board average tenure5.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Per Andersson's remuneration changed compared to Xspray Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-SEK 215m

Mar 31 2024n/an/a

-SEK 213m

Dec 31 2023SEK 4mSEK 3m

-SEK 180m

Sep 30 2023n/an/a

-SEK 180m

Jun 30 2023n/an/a

-SEK 170m

Mar 31 2023n/an/a

-SEK 148m

Dec 31 2022SEK 4mSEK 2m

-SEK 132m

Sep 30 2022n/an/a

-SEK 128m

Jun 30 2022n/an/a

-SEK 114m

Mar 31 2022n/an/a

-SEK 102m

Dec 31 2021SEK 3mSEK 2m

-SEK 97m

Sep 30 2021n/an/a

-SEK 60m

Jun 30 2021n/an/a

-SEK 57m

Mar 31 2021n/an/a

-SEK 56m

Dec 31 2020SEK 3mSEK 2m

-SEK 52m

Sep 30 2020n/an/a

-SEK 56m

Jun 30 2020n/an/a

-SEK 55m

Mar 31 2020n/an/a

-SEK 49m

Dec 31 2019SEK 3mSEK 2m

-SEK 46m

Sep 30 2019n/an/a

-SEK 41m

Jun 30 2019n/an/a

-SEK 34m

Mar 31 2019n/an/a

-SEK 30m

Dec 31 2018SEK 2mSEK 2m

-SEK 23m

Sep 30 2018n/an/a

-SEK 17m

Jun 30 2018n/an/a

-SEK 16m

Mar 31 2018n/an/a

-SEK 8m

Dec 31 2017SEK 2mSEK 1m

-SEK 14m

Compensation vs Market: Per's total compensation ($USD364.55K) is below average for companies of similar size in the UK market ($USD761.35K).

Compensation vs Earnings: Per's compensation has increased whilst the company is unprofitable.

CEO

Per Andersson (57 yo)

18.6yrs

Tenure

SEK 3,743,000

Compensation

Dr. Per Andersson Ph.D. has been the Chief Executive Officer of Xspray Pharma AB (publ) since 2006. Dr. Andersson serves as the Chief Executive Officer of Xspray Microparticles AB. Dr. Andersson joined XSp...

Leadership Team

NamePositionTenureCompensationOwnership
Per Andersson
Chief Executive Officer18.6yrsSEK 3.74m0.57%
SEK 10.0m
Mustafa Demirbüker
Co-Founder and Science Directorno datano datano data
Niklas Adenborg
Chief Financial Officerless than a yearno datano data
Linda Glimberg
Chief Operating Officerless than a yearno data0.0053%
SEK 93.0k
Kerstin Hasselgren
Senior Advisor & Head of IRless than a yearno data0.024%
SEK 426.4k
Charlotta Liljebris
Senior Vice President of Research & Development6.6yrsno data0.0089%
SEK 155.2k
Edward Jordan
Chief Commercial Officerless than a yearno datano data
Anette Abrahamsson
Senior Vice President of Regulatory Affairsless than a yearno data0.0044%
SEK 77.5k
Christer Hallgren
Senior Vice President of Intellectual Property6.6yrsno data0.089%
SEK 1.6m

0.8yrs

Average Tenure

56.5yo

Average Age

Experienced Management: XSPRAS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Maris Hartmanis
Independent Director9.6yrsSEK 323.00k0.092%
SEK 1.6m
Carl-Johan Spak
Independent Director9.6yrsSEK 270.00kno data
Anders Ekblom
Chairman3.3yrsSEK 510.00k1.71%
SEK 29.9m
Torbjörn Koivisto
Independent Director7.6yrsSEK 253.00kno data
Christine Lind
Independent Director5.3yrsSEK 270.00kno data
Anders Bladh
Director3.3yrsSEK 253.00k2.49%
SEK 43.5m
Robert Molander
Independent Director2.3yrsSEK 218.00k0.030%
SEK 517.0k

5.3yrs

Average Tenure

66yo

Average Age

Experienced Board: XSPRAS's board of directors are considered experienced (5.3 years average tenure).